New Results
Phenotype-driven identification of drug targets for post-COVID-19 anosmia
View ORCID ProfileVictoria M. Catterson, Yolanda Sanchez, Gabriel Musso
doi: https://doi.org/10.1101/2022.08.03.502673
Victoria M. Catterson
aBioSymetrics Inc
Yolanda Sanchez
aBioSymetrics Inc
Gabriel Musso
aBioSymetrics Inc
Article usage
Posted August 04, 2022.
Phenotype-driven identification of drug targets for post-COVID-19 anosmia
Victoria M. Catterson, Yolanda Sanchez, Gabriel Musso
bioRxiv 2022.08.03.502673; doi: https://doi.org/10.1101/2022.08.03.502673
Subject Area
Subject Areas
- Biochemistry (11736)
- Bioengineering (8746)
- Bioinformatics (29186)
- Biophysics (14964)
- Cancer Biology (12084)
- Cell Biology (17401)
- Clinical Trials (138)
- Developmental Biology (9418)
- Ecology (14176)
- Epidemiology (2067)
- Evolutionary Biology (18299)
- Genetics (12235)
- Genomics (16793)
- Immunology (11863)
- Microbiology (28066)
- Molecular Biology (11580)
- Neuroscience (60925)
- Paleontology (451)
- Pathology (1870)
- Pharmacology and Toxicology (3238)
- Physiology (4956)
- Plant Biology (10422)
- Synthetic Biology (2883)
- Systems Biology (7338)
- Zoology (1650)